Our
Applications
Barcoding
Technology
Disease
Models
Our
Applications
Decoding Biology
for Tailored Medications
Highlights:
New state-of-the-art facility for Systasy
May 7th, 2025
Barcoding
Technology
Barcoding Technology
safetyPROFILER reveals efficacy, potency and side effects of drugs
Oct 15th 2024
Multiplexable & Parallel Assays
Disease
Models
Human Disease Models
Single-Cell/Nucleus Sequencing Service
July 30, 2024
Patient Derived Cellular Model Systems
Highly multiplexable pathway activity screens
Deeply characterized patient-derived disease models
Technology that powers your viral vector development for gene therapy
Dissect the complexity of heterogenous tissues at unparalleled resolution
We aim to gain deep insights into disease mechanisms and accelerate the development of effective treatments. With our pathway-focused approach, targets and drug candidates discovered from our platform address the truly relevant disease causes and display a markedly increased likelihood of being highly effectives.
Systasy’s technology is unique as it uses millions of molecular barcodes combined with human disease models to analyze hundreds of pathological processes simultaneously. It connects thousands of compound activities to an individual patient’s clinical and genomic data. Systasy’s technology lowers failure in subsequent clinical phases and leads to cost savings for our partners.
Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.
Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.
